Correction to “Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long‐Term Outcome”
Fuente:
Wiley Open Access
Saved in:
| Format: | Artículo Open Access |
|---|---|
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis
by: Jennifer L. Cohen, et al.
Published: (2026)
by: Jennifer L. Cohen, et al.
Published: (2026)
Long‐Term Safety and Efficacy of Pegvaliase in Japanese Adults With Phenylketonuria: Final Results of a Phase III Trial
by: Yoko Nakajima, et al.
Published: (2026)
by: Yoko Nakajima, et al.
Published: (2026)
Correction to “Expanding the Genetic and Clinical Spectrum of SLC25A42 Associated Disorders and Testing of Pantothenic Acid to Improve CoA Level In Vitro”
Published: (2025)
Published: (2025)
Clinical Outcomes and Management in Late Diagnosed Siblings Affected With Attenuated GSD Ib
by: Gregory Lynch, et al.
Published: (2026)
by: Gregory Lynch, et al.
Published: (2026)
Female Patients With Mucopolysaccharidosis II ( MPS II ): Insights From the Hunter Outcome Survey
by: Barbara K. Burton, et al.
Published: (2025)
by: Barbara K. Burton, et al.
Published: (2025)
Clinical and Developmental Outcomes After 50 Years of Newborn Bloodspot Screening for Classical Galactosaemia in the Republic of Ireland
by: D. Pereira, et al.
Published: (2025)
by: D. Pereira, et al.
Published: (2025)
The Management and Clinical Outcomes of Pregnancy in a Female With Glycogen Storage Disease Type IIIA Caused by Rare Variant
by: Nuria Puente‐Ruiz, et al.
Published: (2025)
by: Nuria Puente‐Ruiz, et al.
Published: (2025)
Neurological Outcomes of Newborn Screening‐Identified Isovaleric Acidemia: A Case Series Exploring Initial C5 Acylcarnitine Levels
by: Sharmila Kiss, et al.
Published: (2026)
by: Sharmila Kiss, et al.
Published: (2026)
Nutrition With Skimmed Breast Milk in an Infant With Long Chain 3‐Hydroxyacyl‐coA Dehydrogenase Deficiency
by: Clara Alonso‐Diaz, et al.
Published: (2025)
by: Clara Alonso‐Diaz, et al.
Published: (2025)
Mental and Physical Health in Wilson Disease Patients With SARS‐CoV‐2 Infection and Relevance of Long‐COVID
by: Isabelle Mohr, et al.
Published: (2025)
by: Isabelle Mohr, et al.
Published: (2025)
Retrospective Case Series of Fulminant Metabolic Crisis in GSDIA : Persistent Lactic Acidosis Despite Correction of Hypoglycemia May Reflect Secondary Mitochondrial Dysfunction
by: Herodes Guzman, et al.
Published: (2025)
by: Herodes Guzman, et al.
Published: (2025)
Efzimfotase Alfa Improves Respiratory Capacity in Muscle Tissue From a Mouse Model of HPP
by: Denise Devore, et al.
Published: (2025)
by: Denise Devore, et al.
Published: (2025)
Liver Transplantation and Other Hepatically Directed Therapies Do Not Change the Biochemical Phenotype nor Halt Progression of Leukodystrophy due to Biallelic HMBS Variants: A Case Report
by: Jeremy Clark, et al.
Published: (2025)
by: Jeremy Clark, et al.
Published: (2025)
Efficacy of Switching Therapy From Alglucosidase Alfa to Avalglucosidase Alfa on Respiratory Function in Participants With Late‐Onset Pompe Disease: A Post Hoc Analysis From the COMET Trial
by: Priya S. Kishnani, et al.
Published: (2025)
by: Priya S. Kishnani, et al.
Published: (2025)
Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders Emphasizes the Need for Multitier Testing and Collaborative Approaches to Management
by: A. Terrell, et al.
Published: (2025)
by: A. Terrell, et al.
Published: (2025)
An atypical presentation in a child with propionic acidemia? Better think twice!
by: Tim Burkhardt, et al.
Published: (2025)
by: Tim Burkhardt, et al.
Published: (2025)
A Mild Juvenile Onset Canavan Disease With Atypical Clinical Presentation and MRI Brain Features
by: Preeya Rehsi, et al.
Published: (2025)
by: Preeya Rehsi, et al.
Published: (2025)
2‐[18F] FDG PET/CT in Rapid Late‐Onset Multiple Acyl‐CoA Dehydrogenase Deficiency: A Case Report
by: Astrid Høj, et al.
Published: (2025)
by: Astrid Høj, et al.
Published: (2025)
Psychosocial Challenges Facing Young People With Inherited Metabolic Disorders and Their Parents: A Systematic Review
by: Clara Sherlock, et al.
Published: (2025)
by: Clara Sherlock, et al.
Published: (2025)
Glycine N‐Acyltransferase Deficiency due to a Homozygous Nonsense Variant in the GLYAT: A Novel Inborn Error of Metabolism
by: Mona Nourbakhsh, et al.
Published: (2025)
by: Mona Nourbakhsh, et al.
Published: (2025)
Successful Management of Two Consecutive Pregnancies With Maternal–Fetal Phenylketonuria: Lessons From Clinical Practice
by: Per Lundkvist, et al.
Published: (2025)
by: Per Lundkvist, et al.
Published: (2025)
Atypical Presentation of IARS1‐Related Disorder: Expanding the Phenotype and Genotype
by: Parith Wongkittichote, et al.
Published: (2025)
by: Parith Wongkittichote, et al.
Published: (2025)
Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and Preeclampsia
by: V. Laufs, et al.
Published: (2025)
by: V. Laufs, et al.
Published: (2025)
Treatment of Single Patient With PMM2 ‐Congenital Disorder of Glycosylation With Govorestat ( AT ‐007), an Aldose Reductase Inhibitor
by: Elizabeth R. Jalazo, et al.
Published: (2025)
by: Elizabeth R. Jalazo, et al.
Published: (2025)
Self‐Reported Liver Disease and the Burden of Erythropoietic Protoporphyria
by: Hetanshi Naik, et al.
Published: (2025)
by: Hetanshi Naik, et al.
Published: (2025)
Splenic Artery Aneurysm in Gaucher Disease: A Hybrid Study Combining Case Report, Scoping Review, and Clinical Survey
by: Paolo Manzi, et al.
Published: (2025)
by: Paolo Manzi, et al.
Published: (2025)
Phenotypic variability and the gender paradox in the R363C variant of Fabry disease
by: Alison C. Leslie, et al.
Published: (2025)
by: Alison C. Leslie, et al.
Published: (2025)
D,L‐3‐hydroxybutyrate in the treatment of glucose transporter 1 deficiency syndrome (Glut1DS)
by: Aya Amer, et al.
Published: (2025)
by: Aya Amer, et al.
Published: (2025)
Liver transplantation in glycogen storage disease type III: A case‐series
by: Simon Gay, et al.
Published: (2025)
by: Simon Gay, et al.
Published: (2025)
Holocarboxylase Synthetase Deficiency: A Second Case Report With Neonatal Cholestatic Liver Disease
by: Sophie Manoy, et al.
Published: (2025)
by: Sophie Manoy, et al.
Published: (2025)
Small Molecules as Alternate Substrates for 3‐Methylglutaconylation
by: Elizabeth A. Jennings, et al.
Published: (2025)
by: Elizabeth A. Jennings, et al.
Published: (2025)
Course of Pregnancy in a Woman With Familial Chylomicronemia Syndrome Treated With Plozasiran, a Small Interfering RNA Against ApoC3
by: Miriam Larouche, et al.
Published: (2025)
by: Miriam Larouche, et al.
Published: (2025)
Elevated Transaminases: Does It Always Warrant a Liver Biopsy? Lessons Learned From Pompe Disease
by: Alicia Khazzeka, et al.
Published: (2025)
by: Alicia Khazzeka, et al.
Published: (2025)
Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan
by: Nobuhiko Okamoto, et al.
Published: (2025)
by: Nobuhiko Okamoto, et al.
Published: (2025)
A Multisystem Perspective of Pediatric Cell Trafficking Disorders: Within the Cells, Beneath the Signs
by: Merve Yoldaş Çelik, et al.
Published: (2025)
by: Merve Yoldaş Çelik, et al.
Published: (2025)
Issue Information
Published: (2025)
Published: (2025)
Benefits of Integrated Social Care in the Management of Patients With Inborn Errors of Metabolism
by: A. Selvanathan, et al.
Published: (2025)
by: A. Selvanathan, et al.
Published: (2025)
Severe neonatal hypotonia due to SLC30A5 variant affecting function of ZnT5 zinc transporter
by: Vadim Dolgin, et al.
Published: (2025)
by: Vadim Dolgin, et al.
Published: (2025)
Systemic Primary Carnitine Deficiency Presenting With Substantia Nigra and Basal Ganglia Injury: A Case Report
by: Tomoki Saito, et al.
Published: (2025)
by: Tomoki Saito, et al.
Published: (2025)
Treatment Beliefs Reflect Unmet Clinical Needs in Lysosomal Storage Diseases: An Opportunity for a Patient‐Centered Approach
by: Eleonore M. Corazolla, et al.
Published: (2025)
by: Eleonore M. Corazolla, et al.
Published: (2025)
Similar Items
-
Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis
by: Jennifer L. Cohen, et al.
Published: (2026) -
Long‐Term Safety and Efficacy of Pegvaliase in Japanese Adults With Phenylketonuria: Final Results of a Phase III Trial
by: Yoko Nakajima, et al.
Published: (2026) -
Correction to “Expanding the Genetic and Clinical Spectrum of SLC25A42 Associated Disorders and Testing of Pantothenic Acid to Improve CoA Level In Vitro”
Published: (2025) -
Clinical Outcomes and Management in Late Diagnosed Siblings Affected With Attenuated GSD Ib
by: Gregory Lynch, et al.
Published: (2026) -
Female Patients With Mucopolysaccharidosis II ( MPS II ): Insights From the Hunter Outcome Survey
by: Barbara K. Burton, et al.
Published: (2025)